Thursday, February 1, 2007
12111

A Retrospective Study Investigating The Effectiveness and Economics Of Using Adjunctive Cell Proliferation Induction Wound Therapy To Improve Severe Pressure Ulcer Evidence-based Health Outcomes In A Veteran Spinal Cord Injury Patient Population

Anh Vu, MD and Garrett Harper, MD.

Objective: The Department of Veteran's Affairs (VA) has the single largest network for spinal cord injury (SCI) programs and provides care for nearly 23,000 veteran's with SCI. Many VA SCI patients are noted to suffer from chronic pressure ulcers and other non-healing wounds.

Chronic wounds occur when healing fails to advance through one of the traditional stages of inflammation, proliferation and remodeling. Cell Proliferation Technology (CPI) facilitates wound healing using radio frequency stimulation to induce growth factor expression and cell proliferation. We seek to retrospectively study the clinical results and cost-effectiveness of Cell Proliferation Technology (CPI) using the Provant Wound Closure System in treating chronic pressure ulcers.

Method: Retrospective analysis of a consecutive series of fifty-three patients who have received or are receiving wound treatment using the Provant Wound Closure System at the Veterans Administration Medical Center in Augusta, Georgia. Outcomes will be assessed using the National Pressure Ulcer Association's (www.npuap.org) standardized mapping program called the Pressure Ulcer Scale for Healing (PUSH) tool to determine the rate of reduction in PUSH score (points/month) and total time to healing (reduction of PUSH score to 0).